Home/Filings/4/0000950170-25-090199
4//SEC Filing

Tyagarajan Seshu 4

Accession 0000950170-25-090199

CIK 0001841387other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 8:30 AM ET

Size

4.8 KB

Accession

0000950170-25-090199

Insider Transaction Report

Form 4
Period: 2025-06-25
Tyagarajan Seshu
Chief Technology Officer
Transactions
  • Award

    Common Stock

    2025-06-25$4.67/sh+5,353$24,99990,865 total
Footnotes (1)
  • [F1]Represents shares acquired from the Issuer in a registered direct offering pursuant to the terms of a Securities Purchase Agreement dated as of June 23, 2025.

Documents

1 file

Issuer

Candel Therapeutics, Inc.

CIK 0001841387

Entity typeother

Related Parties

1
  • filerCIK 0001923794

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 8:30 AM ET
Size
4.8 KB